Immunology

REACH is an experienced thought leader in the immunology space. Our team has conducted research across many autoimmune and inflammatory diseases, both rare and non-rare.

DISEASES WE COVER

The immunology space has evolved from reliance on broadly immunosuppressive treatment to the approval of multiple targeted disease modifying agents. Current immunology dynamics the REACH team is tracking include:

  • “Pipeline in a product” emerging therapies like efgartigimod
  • Novel mechanisms of action in development that offer more targeted approaches (e.g., IgG regulation, complement inhibition, T- and B-cell targets)
  • Increasing competition in markets like Hereditary Angioedema (HAE)
See our rare immunology solutions

Search Immunology diseases we cover

Disease
Common Variable Immunodeficiency
Common Variable Immunodeficiency
Graft Versus Host Disease
Graft Versus Host Disease
Hereditary Angioedema
Hereditary Angioedema
Immunoglobin G4-Related Disease
Immunoglobin G4-Related Disease
Mixed Connective Tissue Disease
Mixed Connective Tissue Disease
Primary Agammaglobulinemia
Primary Agammaglobulinemia
WHIM Syndrome
WHIM Syndrome
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Disease
Common Variable Immunodeficiency
Common Variable Immunodeficiency
Graft Versus Host Disease
Graft Versus Host Disease
Hereditary Angioedema
Hereditary Angioedema
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Browse contacts:
1 2 3

Schedule a immunology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare immunology market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare autoimmune conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any immunology disease allow easy comparison across the immunology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for immunologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us